Cargando…
Cardioprotective Effects of ω-3 PUFAs in Chronic Kidney Disease
The prevalence rate of chronic kidney disease (CKD) is increasing worldwide, and cardiovascular disease (CVD) is a main cause of death in patients with CKD. The high incidence of CVD in CKD patients is related to chronic inflammation, dyslipidemia, malnutrition, atherosclerosis, and vascular calcifi...
Autores principales: | Lee, Su Mi, An, Won Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638711/ https://www.ncbi.nlm.nih.gov/pubmed/23653897 http://dx.doi.org/10.1155/2013/712949 |
Ejemplares similares
-
ω-3 PUFAs in the Prevention and Cure of Inflammatory, Degenerative, and Neoplastic Diseases
por: Cittadini, Achille, et al.
Publicado: (2013) -
Relevance of ω-6 GLA Added to ω-3 PUFAs Supplements for ADHD: A Narrative Review
por: D’Helft, Jelle, et al.
Publicado: (2022) -
ω-3 PUFAs and Resveratrol Differently Modulate Acute and Chronic Inflammatory Processes
por: Schwager, Joseph, et al.
Publicado: (2015) -
A Low ω-6 to ω-3 PUFA Ratio (n–6:n–3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth
por: Van Name, Michelle A, et al.
Publicado: (2020) -
ω-3 PUFAs in the Prevention and Cure of Inflammatory, Degenerative, and Neoplastic Diseases 2014
por: Weylandt, Karsten H., et al.
Publicado: (2015)